Evidence map›Paper›PMID 39630397›Full record

Trial reportJournal of clinical monitoring and computing2025

A novel wearable bioimpedance sensor for continuous monitoring of fluid balance: a study on isotonic hypovolemia in healthy adults.

Harald Noddeland, Frida Bremnes, Anne Thorud, Katrine Rolid, Jørn Kvaerness, Ellen Andreassen Jaatun, Sigve Nyvik Aas

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Journal of clinical monitoring and computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05129358 (Testing of an Electronic Patch During Dehydration in Healthy Volunteers), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05129358 nacompletednot on this map

Testing of an Electronic Patch During Dehydration in Healthy Volunteers

TypeinterventionalSponsorMode Sensors ASRan2022 to 2023Enrolled31ConditionsDehydrationArmsDehydration, Rehydration
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Wireless arm-worn bioimpedance sensor for continuous assessment of whole-body hydration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Harald NoddelandDivision of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
Frida BremnesMode Sensors AS, Trondheim, Norway.ORCID 0009-0005-3018-2604
Anne ThorudDivision of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
Katrine RolidDivision of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-0670-9312
Jørn KvaernessMode Sensors AS, Trondheim, Norway.
Ellen Andreassen JaatunMode Sensors AS, Trondheim, Norway.ORCID 0000-0002-1562-1593
Sigve Nyvik AasMode Sensors AS, Trondheim, Norway. sigve.aas@modesensors.com.ORCID 0000-0003-1196-0632

Funding

Research Council of Norway 313922
6 · The paper itself

Abstract

purposeThis study aimed to investigate the ability of a novel wearable bioimpedance sensor to monitor changes in fluid balance induced by furosemide. Because iso-osmotic fluid loss is expected to primarily comprise fluid from the extracellular compartment it was hypothesized that isotonic hypovolemia would increase the extracellular resistance (R

methods27 healthy adults (20 women, 7 men; 35 ± 10 year.) were continuously monitored by the bioimpedance sensor following administration of furosemide. Body weight, blood pressure, heart rate, sensation of thirst and selected blood parameters were tested before furosemide administration (t0), one hour (t1) and two hours (t2) after furosemide administration, and one hour after intake of a sports drink containing carbohydrate and electrolytes (t3). Urine elimination was measured throughout the intervention, and the change in extracellular fluid volume was estimated using urine elimination and established equations.

resultsDuring hypovolemia body weight was reduced by 1.4 ± 0.2 kg (1.7 ± 0.4%). Total urine elimination during fluid loss was 1277 ± 190 mL. R

conclusionThis study demonstrates that the wearable bioimpedance device tested is very sensitive to furosemide-induced changes in fluid volume in healthy volunteers in a controlled environment. Additional research is needed to evaluate the ability of the device to track fluid status in a clinical setting.

trial registrationThe study was registered at clinicaltrials.gov 29th of October 2021 (NCT05129358).

Indexed as

HypovolemiaWater-Electrolyte BalanceWearable Electronic DevicesAdultBlood PressureBody WeightDiureticsElectric ImpedanceExtracellular FluidFemaleFurosemideHealthy VolunteersHeart RateHumansMaleMiddle AgedDiureticsFurosemideBioimpedance spectroscopyDehydrationFluid balanceHydrationWearable sensor

Identifiers

PMID39630397
PMCPMC12049328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.